TERBINAFINE TABLETS 250 MG

TERBINAFINE TABLETS 250 MG was reported 1284 times

TERBINAFINE TABLETS 250 MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 KERION 3 0.2308
1 DISABILITY ASSESSMENT SCALE 1 0.1667
2 EXTRARENAL PELVIS 1 0.1000
3 TINEA FACIEI 2 0.1000
4 ACRODERMATITIS 1 0.0714
5 SKIN HYPERPLASIA 3 0.0526
6 ACUTE LYMPHOCYTIC LEUKAEMIA (IN REMISSION) 1 0.0526
7 RADICULITIS BRACHIAL 3 0.0280
8 ACANTHAMOEBA KERATITIS 1 0.0270
9 EUSTACHIAN TUBE PATULOUS 1 0.0244
10 BLOOD OSMOLARITY ABNORMAL 1 0.0227
11 INFECTION MASKED 2 0.0185
12 ANAMNESTIC REACTION 1 0.0161
13 TRICHOPHYTOSIS 3 0.0142
14 TRANSIENT ACANTHOLYTIC DERMATOSIS 4 0.0136
15 ACTINIC ELASTOSIS 1 0.0132
16 NECROTISING SOFT TISSUE INFECTION 3 0.0130
17 BREAST PROSTHESIS REMOVAL 1 0.0123
18 TINEA VERSICOLOUR 4 0.0111
19 CERVICAL POLYP 4 0.0106
20 NAIL PITTING 4 0.0101
21 INTERTRIGO 5 0.0092
22 FUNGAL FOOT INFECTION 4 0.0091
23 EXTRAVASATION BLOOD 2 0.0084
24 CONJUNCTIVAL EROSION 1 0.0083
25 CALCIUM IONISED DECREASED 2 0.0082
26 MYOGLOBIN URINE PRESENT 2 0.0081
27 ECZEMA WEEPING 1 0.0076
28 ALLOGENIC STEM CELL TRANSPLANTATION 1 0.0063
29 PAPILLOMA 2 0.0063
30 COSTOVERTEBRAL ANGLE TENDERNESS 1 0.0061
31 CUTANEOUS LUPUS ERYTHEMATOSUS 11 0.0057
32 LIP DISCOLOURATION 7 0.0055
33 NAIL DYSTROPHY 3 0.0054
34 CATHETER SITE NODULE 1 0.0052
35 ONYCHOMYCOSIS 21 0.0048
36 DUODENAL POLYP 1 0.0047
37 ACUTE ON CHRONIC LIVER FAILURE 1 0.0046
38 LYMPH GLAND INFECTION 2 0.0044
39 PHAEOHYPHOMYCOSIS 2 0.0042
40 BREAST DISORDER FEMALE 1 0.0039
41 PUSTULAR PSORIASIS 13 0.0038
42 DRUG LEVEL ABNORMAL 2 0.0038
43 CATHETERISATION CARDIAC ABNORMAL 1 0.0037
44 CHOLESTEATOMA 1 0.0036
45 DENTAL PLAQUE 1 0.0036
46 AUTOANTIBODY POSITIVE 1 0.0036
47 PERIORBITAL PAIN 3 0.0035
48 CHRONIC SPONTANEOUS URTICARIA 4 0.0034
49 MUCOSAL EROSION 3 0.0033
50 ADENOCARCINOMA GASTRIC 3 0.0032
51 TINEA PEDIS 5 0.0031
52 BREAST HAEMORRHAGE 1 0.0030
53 CEREBRAL AMYLOID ANGIOPATHY 1 0.0030
54 COAGULATION TIME SHORTENED 1 0.0030
55 CATHETER SITE IRRITATION 1 0.0030
56 ANASTOMOTIC COMPLICATION 1 0.0029
57 OPHTHALMIC MIGRAINE 2 0.0029
58 CIRCUMORAL OEDEMA 1 0.0029
59 FUSARIUM INFECTION 2 0.0029
60 BONE DEMINERALISATION 3 0.0028
61 BIPOLAR II DISORDER 1 0.0028
62 PATHOGEN RESISTANCE 25 0.0027
63 MENTAL FATIGUE 4 0.0027
64 BREAST RECONSTRUCTION 1 0.0027
65 BRONCHITIS BACTERIAL 2 0.0026
66 ADMINISTRATION SITE REACTION 1 0.0026
67 POLYCYSTIC OVARIES 4 0.0026
68 PUSTULE 6 0.0025
69 HAEMOPERITONEUM 2 0.0025
70 ARTERY DISSECTION 1 0.0024
71 PATERNAL EXPOSURE DURING PREGNANCY 2 0.0023
72 CATHETER SITE PRURITUS 2 0.0023
73 FAECES PALE 5 0.0022
74 DOPAMINE DYSREGULATION SYNDROME 1 0.0022
75 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0022
76 ALLERGY TO PLANTS 1 0.0022
77 CARDIAC PACEMAKER REPLACEMENT 1 0.0022
78 MACULE 6 0.0022
79 EPIDERMAL NECROSIS 2 0.0021
80 AGEUSIA 51 0.0020
81 SKIN OEDEMA 2 0.0020
82 LYMPHOCYTIC INFILTRATION 2 0.0020
83 COMPLICATIONS OF TRANSPLANT SURGERY 1 0.0020
84 DRUG EXPOSURE BEFORE PREGNANCY 2 0.0020
85 APPLICATION SITE INFECTION 1 0.0020
86 OEDEMA MUCOSAL 2 0.0019
87 URETEROLITHIASIS 2 0.0019
88 COATING IN MOUTH 1 0.0019
89 INFUSION SITE BRUISING 4 0.0019
90 ANTINUCLEAR ANTIBODY POSITIVE 6 0.0018
91 BURSITIS INFECTIVE 1 0.0018
92 SEBORRHOEIC DERMATITIS 3 0.0018
93 TINEA INFECTION 2 0.0018
94 LINEAR IGA DISEASE 3 0.0018
95 ECZEMA EYELIDS 1 0.0018
96 MYOCARDIAL INJURY 2 0.0018
97 SKIN WOUND 3 0.0018
98 HYPOCHLORAEMIA 2 0.0017
99 DEVICE MAINTENANCE ISSUE 1 0.0017
100 GROIN ABSCESS 2 0.0017
101 UPPER RESPIRATORY TRACT INFLAMMATION 2 0.0017
102 ALLERGY TO METALS 1 0.0016
103 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
104 EFFUSION 2 0.0015
105 AORTITIS 1 0.0015
106 CERVICAL RADICULOPATHY 1 0.0014
107 DENTAL RESTORATION FAILURE 1 0.0014
108 CONJUNCTIVITIS ALLERGIC 2 0.0013
109 CHOLESTATIC LIVER INJURY 3 0.0013
110 NEURODERMATITIS 5 0.0013
111 IMPETIGO 2 0.0013
112 DERMATITIS CONTACT 15 0.0013
113 ONYCHOLYSIS 2 0.0013
114 CORNEAL TRANSPLANT 1 0.0013
115 PAPULE 9 0.0013
116 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
117 HYPERKERATOSIS 7 0.0013
118 ERYTHRODERMIC PSORIASIS 1 0.0012
119 ILLUSION 2 0.0012
120 CONGESTIVE CARDIOMYOPATHY 5 0.0012
121 CRANIOFACIAL FRACTURE 1 0.0012
122 SPINAL CORD INJURY 2 0.0011
123 HYPERSENSITIVITY VASCULITIS 3 0.0011
124 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0011
125 CANDIDA SEPSIS 1 0.0011
126 MIGRAINE WITH AURA 3 0.0011
127 BONE CONTUSION 1 0.0011
128 NEPHROGENIC ANAEMIA 5 0.0011
129 BLOOD BICARBONATE DECREASED 2 0.0011
130 SKIN SWELLING 9 0.0010
131 ANTIBIOTIC THERAPY 1 0.0010
132 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
133 ECCHYMOSIS 7 0.0010
134 DACTYLITIS 1 0.0010
135 CAROTID ARTERIOSCLEROSIS 1 0.0010
136 RASH PUSTULAR 7 0.0010
137 LATENT TUBERCULOSIS 2 0.0010
138 ORTHOPNOEA 3 0.0009
139 DRUG RESISTANCE 24 0.0009
140 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 1 0.0009
141 SKIN EROSION 3 0.0009
142 HYPERPHOSPHATAEMIA 2 0.0009
143 DANDRUFF 2 0.0009
144 ESSENTIAL TREMOR 1 0.0009
145 CATHETER SITE DISCHARGE 1 0.0009
146 CORTISOL DECREASED 1 0.0009
147 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2 0.0009
148 NECROTISING FASCIITIS 3 0.0009
149 SKIN WEEPING 3 0.0008
150 EMBOLISM ARTERIAL 1 0.0008
151 PANNICULITIS 2 0.0008
152 LYMPHADENITIS 2 0.0008
153 BRONCHITIS CHRONIC 2 0.0008
154 ALLERGY TO CHEMICALS 1 0.0008
155 EYELID IRRITATION 2 0.0008
156 CUTANEOUS T-CELL LYMPHOMA 1 0.0008
157 DACRYOSTENOSIS ACQUIRED 1 0.0008
158 CATHETER SITE PAIN 2 0.0008
159 ANAEMIA POSTOPERATIVE 1 0.0008
160 APLASTIC ANAEMIA 4 0.0008
161 NAIL DISCOLOURATION 3 0.0008
162 EXFOLIATIVE RASH 2 0.0008
163 ERYTHEMA MULTIFORME 7 0.0007
164 OVERWEIGHT 4 0.0007
165 BODY MASS INDEX INCREASED 1 0.0007
166 LIP BLISTER 2 0.0007
167 CARBON DIOXIDE INCREASED 1 0.0007
168 BLOOD PHOSPHORUS INCREASED 2 0.0007
169 HYPERURICAEMIA 3 0.0007
170 RASH MORBILLIFORM 2 0.0007
171 DEATH NEONATAL 1 0.0007
172 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
173 SKIN PLAQUE 6 0.0007
174 AUDITORY DISORDER 1 0.0007
175 NEUTROPHILIA 4 0.0007
176 FIBULA FRACTURE 2 0.0007
177 HYPERTONIC BLADDER 2 0.0007
178 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
179 ADENOVIRUS INFECTION 2 0.0007
180 NECK INJURY 2 0.0007
181 DARK CIRCLES UNDER EYES 1 0.0007
182 COCCYDYNIA 1 0.0007
183 HAEMOGLOBIN INCREASED 3 0.0007
184 MASTICATION DISORDER 2 0.0007
185 CALCULUS URINARY 1 0.0006
186 PORTAL HYPERTENSION 2 0.0006
187 PIGMENTATION DISORDER 4 0.0006
188 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
189 HAEMORRHAGIC STROKE 5 0.0006
190 PREGNANCY WITH IMPLANT CONTRACEPTIVE 3 0.0006
191 FOREIGN BODY SENSATION IN EYES 4 0.0006
192 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
193 ENTEROCOCCAL INFECTION 3 0.0006
194 COLON CANCER METASTATIC 1 0.0006
195 BACTERIAL SEPSIS 2 0.0006
196 LYMPHOCYTE COUNT INCREASED 2 0.0006
197 TOXIC SKIN ERUPTION 6 0.0006
198 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
199 DYSGEUSIA 44 0.0006
200 BLOOD AMYLASE INCREASED 1 0.0006
201 CERVICAL SPINAL STENOSIS 1 0.0006
202 BLOOD CHLORIDE INCREASED 1 0.0006
203 DEPRESSION SUICIDAL 2 0.0006
204 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
205 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
206 CARDIAC ABLATION 1 0.0006
207 ERYTHEMA OF EYELID 3 0.0006
208 CUTANEOUS VASCULITIS 2 0.0005
209 ESSENTIAL HYPERTENSION 1 0.0005
210 CONTRAST MEDIA ALLERGY 1 0.0005
211 ACUTE PULMONARY OEDEMA 3 0.0005
212 ADENOCARCINOMA OF COLON 1 0.0005
213 BLOOD IRON INCREASED 1 0.0005
214 CANDIDA INFECTION 9 0.0005
215 HYPOCALCAEMIA 10 0.0005
216 FACE INJURY 2 0.0005
217 ENTEROCOLITIS 3 0.0005
218 METABOLIC DISORDER 3 0.0005
219 EPIGASTRIC DISCOMFORT 2 0.0005
220 MULTIPLE ALLERGIES 4 0.0005
221 SKIN ODOUR ABNORMAL 2 0.0005
222 ANORECTAL DISORDER 1 0.0005
223 AZOTAEMIA 2 0.0005
224 ENDOPHTHALMITIS 3 0.0005
225 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
226 CARDIAC DISCOMFORT 1 0.0005
227 EAR HAEMORRHAGE 1 0.0005
228 DERMATITIS PSORIASIFORM 1 0.0005
229 TENDON RUPTURE 6 0.0005
230 SPINAL STENOSIS 2 0.0005
231 PHOTOSENSITIVITY REACTION 8 0.0005
232 CAPILLARY LEAK SYNDROME 1 0.0005
233 ANOSMIA 7 0.0005
234 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
235 ANAL PRURITUS 1 0.0005
236 FUNGAL INFECTION 16 0.0005
237 SWELLING OF EYELID 3 0.0005
238 ONYCHOMADESIS 2 0.0005
239 SKIN LESION 13 0.0005
240 EAR SWELLING 1 0.0005
241 CATHETER SITE ERYTHEMA 1 0.0005
242 EXOPHTHALMOS 1 0.0005
243 APPLICATION SITE SCAB 1 0.0005
244 NAIL DISORDER 4 0.0005
245 GASTROINTESTINAL PAIN 5 0.0005
246 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
247 BLOOD CREATINE INCREASED 2 0.0005
248 OCULAR DISCOMFORT 5 0.0004
249 TASTE DISORDER 9 0.0004
250 BLOOD TESTOSTERONE DECREASED 3 0.0004
251 DISLOCATION OF VERTEBRA 1 0.0004
252 IMMUNE THROMBOCYTOPENIA 2 0.0004
253 ISCHAEMIA 2 0.0004
254 COLITIS MICROSCOPIC 2 0.0004
255 LIP SWELLING 14 0.0004
256 SUBCUTANEOUS ABSCESS 2 0.0004
257 SINUS BRADYCARDIA 4 0.0004
258 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
259 BREATH ODOUR 1 0.0004
260 PHARYNGEAL SWELLING 4 0.0004
261 DERMAL CYST 1 0.0004
262 BODY TEMPERATURE DECREASED 4 0.0004
263 ORGANISING PNEUMONIA 2 0.0004
264 HEPATIC ENZYME ABNORMAL 2 0.0004
265 CATHETER SITE HAEMORRHAGE 1 0.0004
266 DERMATITIS EXFOLIATIVE 2 0.0004
267 BRAIN ABSCESS 1 0.0004
268 INSURANCE ISSUE 6 0.0004
269 HYPONATRAEMIA 22 0.0004
270 AORTIC ARTERIOSCLEROSIS 1 0.0004
271 CONCUSSION 3 0.0004
272 ACTINIC KERATOSIS 1 0.0004
273 TONSILLITIS 2 0.0004
274 DRUG-INDUCED LIVER INJURY 12 0.0004
275 PNEUMOTHORAX 6 0.0004
276 PHARYNGOLARYNGEAL PAIN 2 0.0004
277 ANORECTAL DISCOMFORT 2 0.0004
278 ANIMAL BITE 1 0.0004
279 TREATMENT FAILURE 31 0.0004
280 PHOTOPHOBIA 7 0.0004
281 STRESS FRACTURE 2 0.0004
282 HIP SURGERY 2 0.0004
283 EAR CONGESTION 1 0.0004
284 ASTHENOPIA 2 0.0004
285 SPINAL COMPRESSION FRACTURE 3 0.0004
286 DRUG SCREEN FALSE POSITIVE 1 0.0004
287 SKIN FISSURES 7 0.0004
288 ANAL HAEMORRHAGE 1 0.0004
289 SKIN EXFOLIATION 30 0.0004
290 CHROMATURIA 8 0.0004
291 EYE INFECTION 4 0.0004
292 EJACULATION DISORDER 1 0.0004
293 BREAST CANCER STAGE IV 1 0.0004
294 IMPAIRED DRIVING ABILITY 4 0.0004
295 SCAB 4 0.0004
296 NEUROLOGICAL SYMPTOM 2 0.0003
297 EXERCISE TOLERANCE DECREASED 2 0.0003
298 MOUTH SWELLING 2 0.0003
299 RALES 2 0.0003
300 URINE OUTPUT DECREASED 3 0.0003
301 DECREASED INTEREST 2 0.0003
302 EAR INFECTION 9 0.0003
303 SKIN HAEMORRHAGE 5 0.0003
304 CARDIAC PACEMAKER INSERTION 2 0.0003
305 ODYNOPHAGIA 2 0.0003
306 ATYPICAL PNEUMONIA 1 0.0003
307 HEARING IMPAIRED 2 0.0003
308 HYPOAESTHESIA ORAL 5 0.0003
309 CRANIOCEREBRAL INJURY 1 0.0003
310 ADRENAL INSUFFICIENCY 4 0.0003
311 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
312 BLOOD BLISTER 1 0.0003
313 EOSINOPHILIC PNEUMONIA 1 0.0003
314 BREAST CANCER RECURRENT 1 0.0003
315 PHOTOPSIA 2 0.0003
316 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
317 EXPOSURE TO TOXIC AGENT 1 0.0003
318 CHOLESTASIS 6 0.0003
319 APPLICATION SITE VESICLES 2 0.0003
320 VITAMIN D DEFICIENCY 3 0.0003
321 RENAL TUBULAR NECROSIS 3 0.0003
322 DEAFNESS NEUROSENSORY 1 0.0003
323 PULMONARY CONGESTION 4 0.0003
324 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
325 SKIN MASS 2 0.0003
326 POST-TRAUMATIC STRESS DISORDER 2 0.0003
327 BREAST MASS 2 0.0003
328 TOOTH ABSCESS 3 0.0003
329 APPLICATION SITE DRYNESS 1 0.0003
330 IMPAIRED GASTRIC EMPTYING 4 0.0003
331 ABNORMAL LOSS OF WEIGHT 2 0.0003
332 BRONCHOPNEUMONIA 1 0.0003
333 RIB FRACTURE 6 0.0003
334 RESPIRATION ABNORMAL 2 0.0003
335 CERVICAL VERTEBRAL FRACTURE 1 0.0003
336 LYMPHOEDEMA 2 0.0003
337 RESPIRATORY FAILURE 21 0.0003
338 WOUND 8 0.0003
339 ERYTHEMA NODOSUM 1 0.0003
340 CYSTITIS 9 0.0003
341 SEASONAL ALLERGY 4 0.0003
342 PRODUCT SUPPLY ISSUE 2 0.0003
343 CELLULITIS 14 0.0003
344 DISORIENTATION 11 0.0003
345 PARAESTHESIA ORAL 4 0.0003
346 PHARYNGITIS STREPTOCOCCAL 3 0.0003
347 FAECES SOFT 2 0.0003
348 CAROTID ARTERY OCCLUSION 1 0.0003
349 MAJOR DEPRESSION 2 0.0003
350 SENSITIVE SKIN 2 0.0003
351 FOOT DEFORMITY 3 0.0003
352 HYPOPHOSPHATAEMIA 2 0.0003
353 SUNBURN 2 0.0003
354 MALNUTRITION 3 0.0003
355 ORAL PAIN 6 0.0003
356 SKIN INFECTION 3 0.0003
357 CHRONIC SINUSITIS 1 0.0003
358 ANHEDONIA 7 0.0003
359 PAROSMIA 2 0.0003
360 PEMPHIGOID 2 0.0003
361 AUTOIMMUNE THYROIDITIS 1 0.0003
362 ECONOMIC PROBLEM 4 0.0003
363 OSTEOPENIA 4 0.0003
364 BOWEL MOVEMENT IRREGULARITY 2 0.0003
365 PROCEDURAL COMPLICATION 2 0.0003
366 JAUNDICE 7 0.0003
367 SEPSIS 29 0.0003
368 LIMB INJURY 7 0.0003
369 VASCULITIS 3 0.0003
370 RASH MACULAR 9 0.0003
371 HYPOALBUMINAEMIA 2 0.0003
372 THERAPY PARTIAL RESPONDER 4 0.0003
373 ORAL HERPES 5 0.0003
374 PROCEDURAL PAIN 7 0.0003
375 NASAL DISCOMFORT 2 0.0003
376 BLOOD ALBUMIN DECREASED 2 0.0003
377 GINGIVAL PAIN 2 0.0003
378 CANDIDIASIS 1 0.0002
379 BLEPHARITIS 1 0.0002
380 SENSORY LOSS 2 0.0002
381 EYE PAIN 14 0.0002
382 TACHYCARDIA 22 0.0002
383 ENURESIS 1 0.0002
384 FRUSTRATION TOLERANCE DECREASED 2 0.0002
385 APPLICATION SITE DISCOLOURATION 1 0.0002
386 POLYURIA 2 0.0002
387 EXTRAVASATION 1 0.0002
388 ESCHERICHIA INFECTION 2 0.0002
389 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
390 PHARYNGITIS 3 0.0002
391 CYST 3 0.0002
392 AORTIC DISSECTION 1 0.0002
393 RHABDOMYOLYSIS 10 0.0002
394 DRUG INTERACTION 38 0.0002
395 DERMATITIS 5 0.0002
396 AORTIC VALVE INCOMPETENCE 1 0.0002
397 ABSCESS LIMB 1 0.0002
398 CARDIAC FAILURE CHRONIC 1 0.0002
399 PSEUDOMONAS INFECTION 2 0.0002
400 ANOREXIA 3 0.0002
401 SKIN HYPERPIGMENTATION 2 0.0002
402 NECK PAIN 13 0.0002
403 MUSCULOSKELETAL DISCOMFORT 4 0.0002
404 ANURIA 2 0.0002
405 RASH GENERALISED 6 0.0002
406 HIATUS HERNIA 3 0.0002
407 MUSCLE STRAIN 2 0.0002
408 HYSTERECTOMY 2 0.0002
409 PYELONEPHRITIS 2 0.0002
410 DIVERTICULUM INTESTINAL 1 0.0002
411 ABDOMINAL ABSCESS 1 0.0002
412 LYMPHADENOPATHY 8 0.0002
413 DRUG ERUPTION 4 0.0002
414 TOOTH DISORDER 5 0.0002
415 RASH MACULO-PAPULAR 5 0.0002
416 FACIAL PAIN 2 0.0002
417 SINUS CONGESTION 3 0.0002
418 OROPHARYNGEAL DISCOMFORT 2 0.0002
419 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
420 AKATHISIA 3 0.0002
421 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
422 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
423 NIGHT SWEATS 7 0.0002
424 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
425 ATRIAL FIBRILLATION 21 0.0002
426 AGRANULOCYTOSIS 4 0.0002
427 ABORTION INDUCED 2 0.0002
428 BLOOD SODIUM DECREASED 4 0.0002
429 BLOOD URINE PRESENT 4 0.0002
430 INTENTIONAL DOSE OMISSION 6 0.0002
431 MUSCULOSKELETAL PAIN 11 0.0002
432 ENDOMETRIOSIS 1 0.0002
433 SLEEP APNOEA SYNDROME 4 0.0002
434 RASH ERYTHEMATOUS 10 0.0002
435 IMPAIRED QUALITY OF LIFE 3 0.0002
436 DEPRESSED MOOD 11 0.0002
437 AFFECT LABILITY 2 0.0002
438 HYPERCHOLESTEROLAEMIA 2 0.0002
439 LOCALISED INFECTION 5 0.0002
440 LIVER FUNCTION TEST ABNORMAL 6 0.0002
441 SINUSITIS 21 0.0002
442 INFLAMMATORY BOWEL DISEASE 2 0.0002
443 HEPATOMEGALY 2 0.0002
444 KNEE OPERATION 2 0.0002
445 PRURITUS 78 0.0002
446 URTICARIA 34 0.0002
447 OEDEMA 11 0.0002
448 BREATH SOUNDS ABNORMAL 1 0.0002
449 RENAL IMPAIRMENT 17 0.0002
450 LIGAMENT SPRAIN 2 0.0002
451 DIABETIC NEUROPATHY 1 0.0002
452 HAEMATOCRIT DECREASED 4 0.0002
453 PERIPHERAL SWELLING 31 0.0002
454 BLOOD PRESSURE ABNORMAL 4 0.0002
455 APPLICATION SITE SWELLING 1 0.0002
456 SALIVARY HYPERSECRETION 2 0.0002
457 CORONARY ARTERY STENOSIS 1 0.0002
458 EMPHYSEMA 2 0.0002
459 INTENTIONAL SELF-INJURY 4 0.0002
460 DRUG TOLERANCE 1 0.0002
461 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
462 DRUG LEVEL DECREASED 2 0.0002
463 HIP ARTHROPLASTY 3 0.0002
464 SKIN DISCOLOURATION 9 0.0002
465 NEUTROPHIL COUNT INCREASED 2 0.0002
466 INITIAL INSOMNIA 2 0.0002
467 HELICOBACTER INFECTION 2 0.0002
468 MUSCULOSKELETAL CHEST PAIN 3 0.0002
469 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
470 SKIN ULCER 5 0.0002
471 TOOTH LOSS 4 0.0002
472 ACUTE MYELOID LEUKAEMIA 3 0.0002
473 EYE DISCHARGE 2 0.0002
474 PANIC ATTACK 7 0.0002
475 RESPIRATORY TRACT INFECTION 5 0.0002
476 BRAIN FOG 3 0.0002
477 ECZEMA 10 0.0002
478 MOUTH ULCERATION 4 0.0002
479 JOINT DISLOCATION 2 0.0002
480 PRODUCTIVE COUGH 9 0.0002
481 OBESITY 3 0.0002
482 ABSCESS 3 0.0002
483 ANAL FISTULA 1 0.0002
484 IMPAIRED WORK ABILITY 4 0.0002
485 PAIN OF SKIN 5 0.0002
486 ANAL ABSCESS 1 0.0002
487 CHRONIC KIDNEY DISEASE 14 0.0002
488 BIPOLAR DISORDER 2 0.0002
489 SKIN LACERATION 2 0.0002
490 BACK INJURY 2 0.0002
491 ACUTE KIDNEY INJURY 28 0.0002
492 WOUND INFECTION 2 0.0002
493 DEAFNESS UNILATERAL 1 0.0002
494 TOOTH FRACTURE 2 0.0002
495 CHOKING SENSATION 1 0.0002
496 DENTAL CARIES 2 0.0002
497 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
498 ERYTHEMA 37 0.0002
499 SKIN DISORDER 6 0.0002
500 CONFUSIONAL STATE 29 0.0002
501 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
502 CONTUSION 17 0.0002
503 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
504 CHOLECYSTITIS ACUTE 1 0.0002
505 MYOCARDIAL ISCHAEMIA 2 0.0002
506 HAEMATURIA 6 0.0002
507 MICTURITION URGENCY 2 0.0002
508 RASH 76 0.0002
509 TINNITUS 8 0.0002
510 NEOPLASM 2 0.0002
511 PRODUCT SUBSTITUTION ISSUE 10 0.0002
512 BLOOD URIC ACID INCREASED 1 0.0002
513 EOSINOPHILIA 3 0.0002
514 SPLENOMEGALY 2 0.0002
515 ENERGY INCREASED 1 0.0002
516 BRADYKINESIA 1 0.0002
517 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
518 SWELLING FACE 11 0.0002
519 BLOOD CREATININE INCREASED 11 0.0002
520 ACCIDENT 2 0.0002
521 MUSCLE RIGIDITY 2 0.0002
522 GASTROENTERITIS VIRAL 3 0.0002
523 RASH PRURITIC 9 0.0002
524 RESTLESS LEGS SYNDROME 3 0.0002
525 WEIGHT DECREASED 46 0.0002
526 NOCTURIA 2 0.0002
527 DERMATITIS ACNEIFORM 1 0.0002
528 VERTIGO 10 0.0002
529 DISCOMFORT 10 0.0002
530 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
531 HYPERCALCAEMIA 2 0.0002
532 DRUG DIVERSION 1 0.0002
533 ABNORMAL WEIGHT GAIN 2 0.0002
534 HEPATIC ENZYME INCREASED 11 0.0002
535 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
536 ILEUS 2 0.0002
537 APPLICATION SITE IRRITATION 2 0.0002
538 DEPRESSION 36 0.0002
539 HEAD INJURY 5 0.0002
540 MUSCLE ATROPHY 2 0.0002
541 HEPATIC CYTOLYSIS 2 0.0002
542 BURNING SENSATION 11 0.0002
543 HYPOPHAGIA 4 0.0002
544 EYE IRRITATION 9 0.0002
545 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
546 INFUSION SITE PAIN 2 0.0002
547 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
548 INFLAMMATION 8 0.0002
549 EAR PAIN 3 0.0002
550 ANGINA UNSTABLE 1 0.0002
551 SURGERY 9 0.0002
552 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
553 BRADYPHRENIA 1 0.0002
554 ASPERGILLUS INFECTION 1 0.0002
555 BEDRIDDEN 2 0.0002
556 TOOTH INFECTION 2 0.0002
557 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
558 OROPHARYNGEAL PAIN 14 0.0002
559 APPETITE DISORDER 1 0.0002
560 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
561 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
562 COUGH 42 0.0001
563 QUALITY OF LIFE DECREASED 2 0.0001
564 COVID-19 26 0.0001
565 BLOOD BILIRUBIN INCREASED 4 0.0001
566 FEEDING DISORDER 3 0.0001
567 PSORIATIC ARTHROPATHY 6 0.0001
568 PRODUCT TASTE ABNORMAL 2 0.0001
569 OCULAR HYPERAEMIA 7 0.0001
570 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
571 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
572 ACUTE HEPATIC FAILURE 2 0.0001
573 PSORIASIS 19 0.0001
574 PERITONITIS 3 0.0001
575 DROOLING 1 0.0001
576 AUTOIMMUNE HEPATITIS 1 0.0001
577 HYPOMAGNESAEMIA 2 0.0001
578 EXTRASYSTOLES 1 0.0001
579 DEFAECATION URGENCY 1 0.0001
580 APPLICATION SITE REACTION 1 0.0001
581 DUODENAL ULCER 1 0.0001
582 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
583 JOINT INJURY 3 0.0001
584 SUBDURAL HAEMATOMA 2 0.0001
585 HYPERSOMNIA 4 0.0001
586 BALANCE DISORDER 12 0.0001
587 DERMATITIS BULLOUS 1 0.0001
588 APATHY 2 0.0001
589 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
590 ASCITES 4 0.0001
591 CARDIOMYOPATHY 2 0.0001
592 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
593 ARTHROPOD BITE 1 0.0001
594 STEVENS-JOHNSON SYNDROME 3 0.0001
595 HEPATIC FUNCTION ABNORMAL 5 0.0001
596 SNEEZING 3 0.0001
597 ANXIETY 38 0.0001
598 BONE LOSS 2 0.0001
599 BLOOD POTASSIUM DECREASED 4 0.0001
600 BREAST TENDERNESS 1 0.0001
601 APPLICATION SITE PRURITUS 3 0.0001
602 AORTIC ANEURYSM 1 0.0001
603 NEPHROLITHIASIS 6 0.0001
604 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
605 HYPOKALAEMIA 6 0.0001
606 CONDITION AGGRAVATED 39 0.0001
607 BASAL CELL CARCINOMA 2 0.0001
608 PLASMA CELL MYELOMA 5 0.0001
609 BONE DENSITY DECREASED 4 0.0001
610 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
611 AFFECTIVE DISORDER 1 0.0001
612 ARTHRITIS 10 0.0001
613 CHEST DISCOMFORT 13 0.0001
614 ILLNESS 13 0.0001
615 THERAPY INTERRUPTED 9 0.0001
616 RESPIRATORY TRACT CONGESTION 2 0.0001
617 SCIATICA 2 0.0001
618 CHEST PAIN 23 0.0001
619 RHINORRHOEA 8 0.0001
620 MUSCLE TIGHTNESS 2 0.0001
621 FIBROMYALGIA 3 0.0001
622 BACK DISORDER 2 0.0001
623 NEUTROPHIL COUNT DECREASED 5 0.0001
624 ASPHYXIA 1 0.0001
625 INJECTION SITE URTICARIA 3 0.0001
626 ABNORMAL FAECES 1 0.0001
627 IMPAIRED HEALING 4 0.0001
628 VENTRICULAR TACHYCARDIA 2 0.0001
629 DRUG LEVEL INCREASED 2 0.0001
630 CYTOMEGALOVIRUS INFECTION 2 0.0001
631 HYPOAESTHESIA 18 0.0001
632 VIRAL INFECTION 4 0.0001
633 COAGULOPATHY 2 0.0001
634 EOSINOPHIL COUNT INCREASED 1 0.0001
635 POLLAKIURIA 5 0.0001
636 DRY SKIN 16 0.0001
637 HALLUCINATION 9 0.0001
638 NASAL CONGESTION 7 0.0001
639 PRODUCT DOSE OMISSION ISSUE 35 0.0001
640 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
641 HAEMATEMESIS 3 0.0001
642 METRORRHAGIA 2 0.0001
643 HEPATITIS 3 0.0001
644 ANAPHYLACTIC SHOCK 3 0.0001
645 PARANOIA 2 0.0001
646 BLOOD MAGNESIUM DECREASED 1 0.0001
647 CARDIAC MURMUR 1 0.0001
648 DIPLOPIA 3 0.0001
649 DELIRIUM 4 0.0001
650 SEPTIC SHOCK 5 0.0001
651 DEAFNESS 3 0.0001
652 LOCAL SWELLING 2 0.0001
653 GASTRITIS 3 0.0001
654 NASOPHARYNGITIS 21 0.0001
655 DERMATITIS ATOPIC 6 0.0001
656 LYMPHOCYTE COUNT DECREASED 2 0.0001
657 HYPERSENSITIVITY 21 0.0001
658 RENAL FAILURE 15 0.0001
659 CARDIOTOXICITY 1 0.0001
660 THIRST 2 0.0001
661 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
662 CEREBRAL HAEMORRHAGE 4 0.0001
663 FEAR 3 0.0001
664 GOUT 2 0.0001
665 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
666 URINARY TRACT INFECTION 19 0.0001
667 HEART RATE INCREASED 11 0.0001
668 THROAT TIGHTNESS 3 0.0001
669 TOOTHACHE 2 0.0001
670 TREATMENT NONCOMPLIANCE 6 0.0001
671 PARAESTHESIA 17 0.0001
672 FEELING COLD 3 0.0001
673 DECREASED APPETITE 25 0.0001
674 INFLUENZA 12 0.0001
675 EYE SWELLING 4 0.0001
676 HEPATIC STEATOSIS 2 0.0001
677 DEMENTIA 3 0.0001
678 BACTERIAL INFECTION 2 0.0001
679 APPENDICITIS 1 0.0001
680 BLISTER 6 0.0001
681 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
682 FOOT FRACTURE 2 0.0001
683 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 19 0.0001
684 HAEMORRHAGE 11 0.0001
685 PAIN IN EXTREMITY 31 0.0001
686 NEUROPATHY PERIPHERAL 10 0.0001
687 MUSCULOSKELETAL DISORDER 2 0.0001
688 HERPES ZOSTER 6 0.0001
689 LETHARGY 6 0.0001
690 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
691 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
692 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
693 SEIZURE 12 0.0001
694 GLAUCOMA 2 0.0001
695 ATELECTASIS 1 0.0001
696 DYSTONIA 2 0.0001
697 DYSSTASIA 3 0.0001
698 AUTOIMMUNE DISORDER 1 0.0001
699 VISION BLURRED 14 0.0001
700 KIDNEY INFECTION 2 0.0001
701 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
702 DYSPEPSIA 10 0.0001
703 INSOMNIA 27 0.0001
704 ABDOMINAL DISCOMFORT 17 0.0001
705 DISABILITY 2 0.0001
706 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
707 SINUS DISORDER 2 0.0001
708 ABNORMAL BEHAVIOUR 4 0.0001
709 PAIN 62 0.0001
710 BLADDER DISORDER 1 0.0001
711 UPPER LIMB FRACTURE 2 0.0001
712 PRESCRIBED UNDERDOSE 2 0.0001
713 DRY EYE 5 0.0001
714 MYALGIA 17 0.0001
715 LEUKOPENIA 5 0.0001
716 IRRITABILITY 6 0.0001
717 BRAIN INJURY 1 0.0001
718 INJURY 7 0.0001
719 LACRIMATION INCREASED 3 0.0001
720 PRODUCT PHYSICAL ISSUE 2 0.0001
721 DYSPNOEA 56 0.0001
722 BONE MARROW FAILURE 2 0.0001
723 FLUSHING 10 0.0001
724 EAR DISCOMFORT 1 0.0001
725 THERAPY CESSATION 5 0.0001
726 PRODUCT USE IN UNAPPROVED INDICATION 24 0.0001
727 PULMONARY HYPERTENSION 2 0.0001
728 PANCREATITIS 5 0.0001
729 OSTEOARTHRITIS 4 0.0001
730 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
731 EATING DISORDER 2 0.0001
732 RETCHING 2 0.0001
733 BODY HEIGHT DECREASED 1 0.0001
734 MOVEMENT DISORDER 3 0.0001
735 LIVER FUNCTION TEST INCREASED 2 0.0001
736 RECTAL HAEMORRHAGE 4 0.0001
737 POOR QUALITY SLEEP 2 0.0001
738 HOT FLUSH 7 0.0001
739 DISTURBANCE IN ATTENTION 5 0.0001
740 MUSCLE SPASMS 17 0.0001
741 PRURITUS GENERALISED 2 0.0001
742 BLOOD PRESSURE INCREASED 14 0.0001
743 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
744 ARTHRALGIA 38 0.0001
745 ASPIRATION 1 0.0001
746 STAPHYLOCOCCAL INFECTION 3 0.0001
747 BACK PAIN 21 0.0001
748 BLOOD PRESSURE DECREASED 6 0.0001
749 ARTHROPATHY 5 0.0001
750 URINARY RETENTION 3 0.0001
751 EYE PRURITUS 3 0.0001
752 RASH PAPULAR 2 0.0001
753 PANCREATITIS ACUTE 2 0.0001
754 BLOOD CALCIUM DECREASED 1 0.0001
755 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
756 VISUAL IMPAIRMENT 11 0.0001
757 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
758 PRODUCT AVAILABILITY ISSUE 2 0.0001
759 NAUSEA 69 0.0001
760 THROMBOSIS 7 0.0001
761 PERICARDIAL EFFUSION 2 0.0001
762 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
763 ABDOMINAL DISTENSION 9 0.0001
764 SWELLING 8 0.0001
765 PALPITATIONS 10 0.0001
766 ASTHENIA 32 0.0001
767 SLEEP DISORDER 6 0.0001
768 DYSPHAGIA 8 0.0001
769 BACTERAEMIA 1 0.0001
770 DISEASE RECURRENCE 4 0.0001
771 CATARACT 5 0.0001
772 SKIN BURNING SENSATION 6 0.0001
773 EMOTIONAL DISTRESS 10 0.0001
774 CRYING 3 0.0001
775 STOMATITIS 5 0.0001
776 BURSITIS 1 0.0001
777 CEREBRAL INFARCTION 2 0.0001
778 DYSURIA 3 0.0001
779 FATIGUE 63 0.0001
780 EPISTAXIS 6 0.0001
781 DIZZINESS 40 0.0001
782 PNEUMONIA ASPIRATION 2 0.0001
783 ASTHMA 9 0.0001
784 BRAIN OEDEMA 1 0.0001
785 COLITIS 3 0.0001
786 FALL 26 0.0001
787 LOSS OF CONSCIOUSNESS 10 0.0001
788 ERECTILE DYSFUNCTION 2 0.0001
789 PNEUMONIA 25 0.0001
790 EXPOSURE VIA SKIN CONTACT 2 0.0001
791 SUICIDAL IDEATION 7 0.0001
792 SPEECH DISORDER 4 0.0001
793 ANKYLOSING SPONDYLITIS 1 0.0001
794 DYSMENORRHOEA 1 0.0001
795 FEBRILE NEUTROPENIA 5 0.0001
796 HEADACHE 47 0.0001
797 BREAST CANCER FEMALE 2 0.0001
798 JOINT SWELLING 9 0.0001
799 SOMNOLENCE 15 0.0001
800 DIARRHOEA 48 0.0001
801 BLINDNESS 3 0.0001
802 CONSTIPATION 16 0.0001
803 MOOD ALTERED 2 0.0001
804 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
805 OSTEOPOROSIS 3 0.0001
806 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
807 ABDOMINAL PAIN UPPER 15 0.0001
808 DRUG INEFFECTIVE 96 0.0001
809 ABNORMAL DREAMS 2 0.0001
810 ROAD TRAFFIC ACCIDENT 3 0.0001
811 HAEMOPTYSIS 2 0.0001
812 APHONIA 1 0.0001
813 PANCYTOPENIA 4 0.0001
814 CARPAL TUNNEL SYNDROME 1 0.0001
815 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
816 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
817 TARDIVE DYSKINESIA 2 0.0001
818 PAIN IN JAW 2 0.0001
819 MUSCULAR WEAKNESS 8 0.0001
820 BRONCHOSPASM 1 0.0001
821 SYNCOPE 7 0.0001
822 HYPERHIDROSIS 9 0.0001
823 ANGINA PECTORIS 2 0.0001
824 HYPOACUSIS 3 0.0001
825 MOBILITY DECREASED 5 0.0001
826 PYREXIA 24 0.0001
827 MENTAL DISORDER 3 0.0001
828 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
829 NEEDLE ISSUE 2 0.0001
830 DYSPHONIA 4 0.0001
831 CHILLS 8 0.0001
832 LABORATORY TEST ABNORMAL 2 0.0001
833 PSYCHOTIC DISORDER 2 0.0001
834 LIVER DISORDER 3 0.0001
835 BRONCHITIS 5 0.0001
836 RENAL INJURY 2 0.0001
837 COLITIS ULCERATIVE 3 0.0001
838 COLON CANCER 1 0.0001
839 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
840 RESPIRATORY DISORDER 2 0.0001
841 HEPATIC FAILURE 2 0.0001
842 THERAPEUTIC RESPONSE DECREASED 4 0.0001
843 DEVICE FAILURE 1 0.0001
844 OEDEMA PERIPHERAL 8 0.0001
845 DIABETES MELLITUS 5 0.0001
846 SKIN IRRITATION 3 0.0001
847 FEELING HOT 4 0.0001
848 ANKLE FRACTURE 1 0.0001
849 RENAL DISORDER 3 0.0001
850 DELUSION 1 0.0001
851 BLOOD CHOLESTEROL INCREASED 3 0.0001
852 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
853 PRODUCT USE ISSUE 12 0.0001
854 CYANOSIS 1 0.0001
855 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
856 MOOD SWINGS 2 0.0001
857 MULTIPLE SCLEROSIS 3 0.0001
858 GAIT DISTURBANCE 12 0.0001
859 HYPOTHYROIDISM 2 0.0001
860 INFECTION 9 0.0001
861 HYPOGLYCAEMIA 3 0.0001
862 RHEUMATOID ARTHRITIS 7 0.0001
863 BLOOD POTASSIUM INCREASED 1 0.0001
864 DEEP VEIN THROMBOSIS 4 0.0001
865 ALOPECIA 12 0.0001
866 CHOLELITHIASIS 2 0.0001
867 OSTEONECROSIS 2 0.0001
868 EXPIRED PRODUCT ADMINISTERED 2 0.0001
869 DEHYDRATION 8 0.0001
870 GAIT INABILITY 2 0.0001
871 BLOOD UREA INCREASED 1 0.0001
872 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
873 CIRCULATORY COLLAPSE 1 0.0001
874 HAEMOGLOBIN DECREASED 6 0.0001
875 FEELING ABNORMAL 14 0.0001
876 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
877 INJECTION SITE REACTION 4 0.0001
878 DEVICE USE ISSUE 1 0.0001
879 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
880 AMENORRHOEA 1 0.0001
881 MALAISE 25 0.0001
882 COLD SWEAT 1 0.0001
883 BRADYCARDIA 3 0.0001
884 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
885 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
886 PLATELET COUNT DECREASED 6 0.0001
887 MYELOSUPPRESSION 2 0.0001
888 C-REACTIVE PROTEIN INCREASED 2 0.0001
889 BONE DISORDER 1 0.0001
890 END STAGE RENAL DISEASE 1 0.0001
891 INJECTION SITE MASS 2 0.0001
892 WEIGHT INCREASED 12 0.0001
893 OXYGEN SATURATION DECREASED 3 0.0001
894 DYSARTHRIA 2 0.0001
895 DYSPNOEA EXERTIONAL 2 0.0001
896 INTESTINAL OBSTRUCTION 2 0.0001
897 FLATULENCE 3 0.0001
898 ACNE 4 0.0001
899 HYPERTENSION 11 0.0001
900 ERUCTATION 1 0.0001
901 ABDOMINAL PAIN 12 0.0001
902 BONE PAIN 3 0.0001
903 MEMORY IMPAIRMENT 7 0.0001
904 INJECTION SITE BRUISING 4 0.0001
905 EXTRA DOSE ADMINISTERED 2 0.0000
906 PLEURAL EFFUSION 3 0.0000
907 DYSKINESIA 2 0.0000
908 BODY TEMPERATURE INCREASED 1 0.0000
909 VOMITING 23 0.0000
910 INJECTION SITE PAIN 15 0.0000
911 CARDIAC ARREST 4 0.0000
912 EXPOSURE DURING PREGNANCY 3 0.0000
913 OFF LABEL USE 42 0.0000
914 WITHDRAWAL SYNDROME 2 0.0000
915 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
916 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
917 AMNESIA 3 0.0000
918 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
919 INTENTIONAL PRODUCT MISUSE 4 0.0000
920 APPLICATION SITE PAIN 1 0.0000
921 ANGIOEDEMA 2 0.0000
922 INJECTION SITE PRURITUS 3 0.0000
923 THROMBOCYTOPENIA 5 0.0000
924 DEVICE ISSUE 4 0.0000
925 THROAT IRRITATION 2 0.0000
926 NEUTROPENIA 6 0.0000
927 COGNITIVE DISORDER 2 0.0000
928 DISEASE PROGRESSION 5 0.0000
929 MIGRAINE 4 0.0000
930 BLOOD PRESSURE FLUCTUATION 1 0.0000
931 DIABETIC KETOACIDOSIS 1 0.0000
932 INTERSTITIAL LUNG DISEASE 2 0.0000
933 LUNG DISORDER 2 0.0000
934 ENCEPHALOPATHY 1 0.0000
935 HYPOTENSION 8 0.0000
936 ABDOMINAL PAIN LOWER 1 0.0000
937 APPLICATION SITE ERYTHEMA 1 0.0000
938 BLOOD GLUCOSE INCREASED 7 0.0000
939 DRY MOUTH 3 0.0000
940 ANAEMIA 7 0.0000
941 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
942 INFLUENZA LIKE ILLNESS 3 0.0000
943 HAEMATOCHEZIA 2 0.0000
944 ANAPHYLACTIC REACTION 2 0.0000
945 DIVERTICULITIS 1 0.0000
946 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
947 CEREBROVASCULAR ACCIDENT 6 0.0000
948 CONVULSION 2 0.0000
949 PRODUCT STORAGE ERROR 3 0.0000
950 MUSCULOSKELETAL STIFFNESS 3 0.0000
951 ACUTE MYOCARDIAL INFARCTION 1 0.0000
952 WHEEZING 2 0.0000
953 GASTROINTESTINAL DISORDER 3 0.0000
954 ADVERSE DRUG REACTION 3 0.0000
955 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
956 ILL-DEFINED DISORDER 2 0.0000
957 EMOTIONAL DISORDER 1 0.0000
958 CARDIAC DISORDER 3 0.0000
959 DRUG INTOLERANCE 3 0.0000
960 DRUG DOSE OMISSION 5 0.0000
961 ANGER 1 0.0000
962 DEVICE USE ERROR 1 0.0000
963 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
964 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
965 DRUG EFFECT INCOMPLETE 1 0.0000
966 UNDERDOSE 2 0.0000
967 ACCIDENTAL OVERDOSE 1 0.0000
968 UNEVALUABLE EVENT 2 0.0000
969 HOSPITALISATION 4 0.0000
970 ABORTION SPONTANEOUS 1 0.0000
971 CARDIAC FAILURE 2 0.0000
972 CARDIAC FAILURE CONGESTIVE 2 0.0000
973 DEVICE BREAKAGE 1 0.0000
974 TREMOR 4 0.0000
975 CARDIO-RESPIRATORY ARREST 1 0.0000
976 MYOCARDIAL INFARCTION 4 0.0000
977 ARRHYTHMIA 1 0.0000
978 AGGRESSION 1 0.0000
979 DEATH 17 0.0000
980 TOXICITY TO VARIOUS AGENTS 3 0.0000
981 INJECTION SITE ERYTHEMA 2 0.0000
982 DEVICE EXPULSION 1 0.0000
983 DEVICE DIFFICULT TO USE 1 0.0000
984 PRODUCT QUALITY ISSUE 2 0.0000
985 AGITATION 1 0.0000
986 INCORRECT DOSE ADMINISTERED 3 0.0000
987 DRUG DOSE OMISSION BY DEVICE 1 0.0000
988 COMPLETED SUICIDE 1 0.0000
989 ADVERSE EVENT 1 0.0000
990 BREAST CANCER 1 0.0000